|
NSMCE4A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
1.63868918434673E-12 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.254800E-01 |
| Stage1-vs-Stage3 |
6.660200E-03 |
| Stage1-vs-Stage4 |
2.801900E-03 |
| Stage2-vs-Stage3 |
3.841000E-01 |
| Stage2-vs-Stage4 |
1.537610E-01 |
| Stage3-vs-Stage4 |
4.206800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.25288709699134E-12 |
| Normal-vs-Asian |
1.21429977184562E-10 |
| Caucasian-vs-AfricanAmerican |
7.939400E-01 |
| Caucasian-vs-Asian |
3.154100E-02 |
| AfricanAmerican-vs-Asian |
1.308580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
9.205800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.20370000003633E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.275820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.420430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.676600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.202400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.518600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.112200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.658400E-03 |
| Classical-VS-Follicular |
2.074100E-02 |
| Classical-VS-Other |
9.458800E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
3.98850000000728E-05 |
| Tall-VS-Other |
1.649800E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
4.423200E-01 |
| Follicular-VS-Normal |
7.97130139673641E-11 |
| Other-VS-Normal |
3.50780000002437E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.72650782559458E-12 |
| N0-vs-N1 |
2.575200E-01 |
|
|
